Healthcare Services Group Financial Statements (HCSG)
|
|
Report date
|
|
|
18.02.2022 |
30.06.2022 |
31.12.2022 |
17.02.2023 |
16.02.2024 |
|
25.10.2024 |
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
1 642 |
1 642 |
1 690 |
1 690 |
1 671 |
|
1 709 |
Operating Income, bln rub |
|
|
31.0 |
31.0 |
53.5 |
53.5 |
62.4 |
|
30.2 |
EBITDA, bln rub |
? |
|
77.9 |
45.7 |
45.1 |
62.9 |
75.2 |
|
50.9 |
Net profit, bln rub |
? |
|
48.5 |
45.9 |
34.6 |
34.2 |
38.4 |
|
24.5 |
|
OCF, bln rub |
? |
|
37.1 |
37.1 |
|
-8.17 |
43.5 |
|
20.6 |
CAPEX, bln rub |
? |
|
5.69 |
5.69 |
|
5.21 |
5.41 |
|
2.71 |
FCF, bln rub |
? |
|
31.4 |
31.4 |
|
-13.4 |
38.1 |
|
17.9 |
Dividend payout, bln rub
|
|
|
62.2 |
62.2 |
|
63.4 |
0.000 |
|
0.000 |
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
128.2% |
135.7% |
0.00% |
185.1% |
0.00% |
|
0 |
|
OPEX, bln rub |
|
|
173.1 |
173.1 |
140.3 |
140.3 |
189.1 |
|
230.9 |
Cost of production, bln rub |
|
|
1 415 |
1 415 |
1 496 |
1 496 |
1 420 |
|
1 467 |
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
Interest expenses, bln rub |
|
|
1.39 |
1.39 |
0.000 |
2.99 |
7.86 |
|
3.26 |
|
Assets, bln rub |
|
|
777.5 |
740.1 |
718.3 |
718.3 |
790.7 |
|
805.8 |
Net Assets, bln rub |
? |
|
452.7 |
437.8 |
426.2 |
426.2 |
456.6 |
|
488.7 |
Debt, bln rub |
|
|
11.3 |
9.86 |
0.000 |
33.1 |
36.2 |
|
34.0 |
Cash, bln rub |
|
|
185.2 |
129.2 |
121.5 |
121.5 |
147.5 |
|
103.8 |
Net debt, bln rub |
|
|
-173.9 |
-119.3 |
-121.5 |
-88.4 |
-111.2 |
|
-69.8 |
|
Ordinary share price, rub |
|
|
17.8 |
17.4 |
12.0 |
12.0 |
10.4 |
|
9.86 |
Number of ordinary shares, mln |
|
|
74.8 |
74.8 |
74.3 |
74.3 |
74.3 |
|
73.7 |
|
Market cap, bln rub |
|
|
1 331 |
1 303 |
892 |
892 |
770 |
|
727 |
EV, bln rub |
? |
|
1 157 |
1 183 |
771 |
804 |
659 |
|
657 |
Book value, bln rub |
|
|
357 |
344 |
335 |
335 |
369 |
|
403 |
|
EPS, rub |
? |
|
0.65 |
0.61 |
0.47 |
0.46 |
0.52 |
|
0.33 |
FCF/share, rub |
|
|
0.42 |
0.42 |
0.00 |
-0.18 |
0.51 |
|
0.24 |
BV/share, rub |
|
|
4.77 |
4.60 |
4.50 |
4.50 |
4.97 |
|
5.47 |
|
EBITDA margin, % |
? |
|
4.74% |
2.78% |
2.67% |
3.72% |
4.50% |
|
2.98% |
Net margin, % |
? |
|
2.96% |
2.79% |
2.05% |
2.03% |
2.30% |
|
1.43% |
FCF yield, % |
? |
|
2.36% |
2.41% |
0.00% |
-1.50% |
4.94% |
|
2.47% |
ROE, % |
? |
|
10.7% |
10.5% |
8.13% |
8.04% |
8.41% |
|
5.01% |
ROA, % |
? |
|
6.24% |
6.20% |
4.82% |
4.77% |
4.85% |
|
3.04% |
|
P/E |
? |
|
27.4 |
28.4 |
25.8 |
26.1 |
20.1 |
|
29.7 |
P/FCF |
|
|
42.4 |
41.5 |
|
-66.7 |
20.2 |
|
40.5 |
P/S |
? |
|
0.81 |
0.79 |
0.53 |
0.53 |
0.46 |
|
0.43 |
P/BV |
? |
|
3.73 |
3.79 |
2.67 |
2.67 |
2.09 |
|
1.80 |
EV/EBITDA |
? |
|
14.9 |
25.9 |
17.1 |
12.8 |
8.76 |
|
12.9 |
Debt/EBITDA |
|
|
-2.23 |
-2.61 |
-2.69 |
-1.40 |
-1.48 |
|
-1.37 |
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
|
0.00% |
0.00% |
|
0 |
|
CAPEX/Revenue, % |
|
|
0.35% |
0.35% |
0.00% |
0.31% |
0.32% |
|
0.16% |
|
Healthcare Services Group shareholders |